Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer
Clinical trial NCT04847466 · COMPLETED
Trial details
- NCT number
- NCT04847466
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2025-12-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.